FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/107453 [Registered on: 02/04/2026] Trial Registered Prospectively
Last Modified On: 01/04/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   EVALUATION OF EFFECT OF NAGAVALLI VARTH IN THE MANAGEMENT OF CHRONIC FISSURE-IN-ANO 
Scientific Title of Study   AN OPEN LABEL RANDOMIZED CLINICAL STUDY TO COMPARE THE EFFICACY OF NAGAVALLI VARTH WITH DICLOFENAC SUPPOSITORY IN THE MANAGEMENT OF CHRONIC FISSURE-IN-ANO 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nadhi Suresh 
Designation  PG SCHOLAR 
Affiliation  SRI SRI COLLEGE OF AYURVEDIC SCIENCE HOSPITAL AND RESEARCH 
Address  Department of PG Studies in Shalya Tantra, Sri Sri College of Ayurvedic, 21st KM, Kanakapura main road,
Udayapura Post, Bengaluru 560082 KARNATAKA India
Bangalore
KARNATAKA
560082
India 
Phone  09108254765  
Fax    
Email  nadhisuresh30@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr vivek j 
Designation  PROFESSOR 
Affiliation  SRI SRI COLLEGE OF AYURVEDIC SCIENCE HOSPITAL AND RESEARCH 
Address  Department of PG Studies in Shalya Tantra, Sri Sri College of Ayurvedic, 21st KM, Kanakapura main road,
Udayapura Post, Bengaluru 560082 KARNATAKA India
Bangalore
KARNATAKA
560082
India 
Phone  09108254765  
Fax    
Email  ayurvedabhishak@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nadhi Suresh 
Designation  PG SCHOLAR 
Affiliation  SRI SRI COLLEGE OF AYURVEDIC SCIENCE HOSPITAL AND RESEARCH 
Address  Department of PG Studies in Shalya Tantra, Sri Sri College of Ayurvedic, 21st KM, Kanakapura main road,
Udayapura Post, Bengaluru 560082 KARNATAKA India
Bangalore
KARNATAKA
560082
India 
Phone  09108254765  
Fax    
Email  nadhisuresh30@gmail.com  
 
Source of Monetary or Material Support  
Sri Sri Ayurvedic hospital, 21st KM, Kanakapura main road Udayapura Post, Bengaluru 560082 KARNATAKA India 
 
Primary Sponsor  
Name  Dr Nadhi Suresh 
Address  DEPARTMENT OF PG STUDIES IN SHALYA TANTRA, SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH,21ST KM, KANAKAPURA ROAD BANGALORE KARNATAKA 560082 India  
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nadhi Suresh  SRI SRI COLLAGE OF AYURVEDIC SCIENCE AND RESEARCH  Department of PG Studies in Shalya Tantra, Sri Sri College of Ayurvedic, 21st KM, Kanakapura main road, Udayapura Post, Bengaluru 560082 KARNATAKA India Bangalore KARNATAKA 560082 India
Bangalore
KARNATAKA 
9108254765

nadhisuresh30@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRI SRI INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K928||Other specified diseases of the digestive system. Ayurveda Condition: PARIKARTIKA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Nagavalli varthi, Reference: Kamble SD, Yeola GH, Gaikwad PP, Waghmare AH. Tambula-Sevana as a healthy daily regimen: An Ayurveda overview. WJPR. 2021 Oct;10(12):497–507. doi:10.20959/wjpr202112-21715, Route: Rectal, Dosage Form: Varti/ Suppository, Dose: 2(g), Frequency: bd, Bhaishajya Kal: Madhyabhakta, Duration: 14 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator Arm (Non Ayurveda)-diclofenac suppositoryDiclofenac suppository 100 mg twice a day proved to be an excellent pain management method for fissure in ano cases in outpatient department care
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Diagnosed case of chronic fissure-in-ano duration greater than six weeks
Parikarthika, sadaha, parikartana, anilasanga
Age group: 21 to 70 years, both genders willing to participate
Complaints of pain during defecation, bleeding per rectum, burning sensation, post-defecation
Single posterior anterior fissure on clinical examination.
Willing to give written informed consent.
Willing to comply with the treatment protocol and follow-up visits.  
 
ExclusionCriteria 
Details  Acute fissure-in-ano duration less than 6 weeks.
Pregnant women
Known allergy or hypersensitivity to any components of diclofenac
Psychiatric illness or cognitive impairment
Patients suffering from systemic diseases like hepatitis, tuberculosis, HIV
Patient with associated anorectal disease like fistula in ano, hemorrhoids, polyp,
abscess and malignancy.  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Nagavalli Varthi will result in significant pain reduction and healing of chronic fissure-in-ano compared to Diclofenac suppository.

Severe pain to moderate pain

From moderate to mild pain

Significant healing of ulcer 
14 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in physical and psychological health
 
14th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   THIS STUDY HAS BEEN TAKEN UP TO EVALUATE THE EFFICACY OF NAGAVALLI VARTHI WITH DICLOFENAC SUPPOSITORY IN THE MANAGEMENT OF CHRONIC FISSURE-IN ANO

H0 - There is no significant difference between the efficacy of Nagavalli Varthi and Diclofenac suppository in the management of Chronic fissure-in-ano.

H1 - There is significant difference between the efficacy of Nagavalli Varthi and Diclofenac suppository in the management of Chronic fissure-in-ano. 
 
Close